Ritholtz Wealth Management Has $114,000 Holdings in LifeVantage Co. (NASDAQ:LFVN)

Ritholtz Wealth Management lowered its position in shares of LifeVantage Co. (NASDAQ:LFVN) by 18.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,692 shares of the company’s stock after selling 3,963 shares during the quarter. Ritholtz Wealth Management’s holdings in LifeVantage were worth $114,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Empowered Funds LLC raised its holdings in shares of LifeVantage by 8.1% during the first quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock valued at $461,000 after acquiring an additional 5,742 shares during the period. Acadian Asset Management LLC raised its holdings in shares of LifeVantage by 2.8% during the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after acquiring an additional 6,121 shares during the period. Hillsdale Investment Management Inc. purchased a new position in LifeVantage during the first quarter valued at approximately $76,000. Vanguard Group Inc. grew its position in LifeVantage by 2.8% during the first quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock valued at $2,874,000 after purchasing an additional 12,809 shares in the last quarter. Finally, Hantz Financial Services Inc. purchased a new position in LifeVantage during the second quarter valued at approximately $91,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

LifeVantage Stock Performance

Shares of LFVN opened at $9.77 on Friday. The company’s 50 day moving average price is $7.40 and its 200 day moving average price is $7.01. LifeVantage Co. has a 52 week low of $4.20 and a 52 week high of $10.48. The company has a market capitalization of $124.09 million, a PE ratio of 34.89 and a beta of 0.81.

LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.07). LifeVantage had a net margin of 1.47% and a return on equity of 27.85%. The company had revenue of $48.93 million for the quarter.

LifeVantage Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 17th. Investors of record on Monday, September 9th will be paid a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 1.64%. The ex-dividend date is Monday, September 9th. LifeVantage’s payout ratio is presently 57.14%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.